Heart issues after jabs rare but data not enough

RESEARCH shows that the risk of developing heart conditions after a messenger RNA Covid vaccine is very low and should not call into question the value of life-saving vaccination campaigns rolled out across the world.

But the risk is "non-negligible," and the available evidence is difficult to assess precisely, researchers have said, calling for better data on the subject.